Abstract
The p53 gene is a tumour suppressor gene frequently mutated in human cancers. Its product is a transcription factor that regulates the expression of various genes involved in cell cycle arrest and in apoptosis in response to different cellular stresses. The recent discovery of two p53 gene homologs, p73 and p63, has uncovered a family of transcription factors and widened the scenario of cell cycle control and apoptosis. p73 and p63 genes encode proteins showing significant structural and functional similarity to p53, although important differences are emerging. p73 and p63 have an additional domain in their carboxyl-terminal region with marked similarity to the structure of SAM (sterile alpha motif) domains, typical of proteins involved in development. Indeed, differently from p53, p63 and p73 seem to be involved in development and differentiation. Both p73 and p63, at least when overproduced, can activate some of the p53-responsive promoters and trigger growth arrest and apoptosis, although their an swers in response to DNA damage differ from those of p53. The challenge is now to understand similarities and differences between family members especially in terms of their functions, regulation and interactions. This review summarizes the present knowledge on the structural, functional and evolutionary features of the p53 gene family and focuses on the differences among the three members of the family.
Current Genomics
Title: p53 Gene Family: Structural, Functional and Evolutionary Features
Volume: 4 Issue: 1
Author(s): D'Erchia A. M., Tullo A., Pesole G., Saccone C. and Sbisa E.
Affiliation:
Abstract: The p53 gene is a tumour suppressor gene frequently mutated in human cancers. Its product is a transcription factor that regulates the expression of various genes involved in cell cycle arrest and in apoptosis in response to different cellular stresses. The recent discovery of two p53 gene homologs, p73 and p63, has uncovered a family of transcription factors and widened the scenario of cell cycle control and apoptosis. p73 and p63 genes encode proteins showing significant structural and functional similarity to p53, although important differences are emerging. p73 and p63 have an additional domain in their carboxyl-terminal region with marked similarity to the structure of SAM (sterile alpha motif) domains, typical of proteins involved in development. Indeed, differently from p53, p63 and p73 seem to be involved in development and differentiation. Both p73 and p63, at least when overproduced, can activate some of the p53-responsive promoters and trigger growth arrest and apoptosis, although their an swers in response to DNA damage differ from those of p53. The challenge is now to understand similarities and differences between family members especially in terms of their functions, regulation and interactions. This review summarizes the present knowledge on the structural, functional and evolutionary features of the p53 gene family and focuses on the differences among the three members of the family.
Export Options
About this article
Cite this article as:
M. A. D'Erchia, A. Tullo, G. Pesole, C. Saccone and E. Sbisa, p53 Gene Family: Structural, Functional and Evolutionary Features, Current Genomics 2003; 4 (1) . https://dx.doi.org/10.2174/1389202033350173
DOI https://dx.doi.org/10.2174/1389202033350173 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Finding Drug Targets Through Analysis of the Platelet Transcriptome
Current Pharmaceutical Design Epigenetic Modifications Due to Heavy Metals Exposure in Children Living in Polluted Areas
Current Genomics Aging and Inflammation: Etiological Culprits of Cancer
Current Aging Science Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Anti-Cancer Agents in Medicinal Chemistry Molecular Mechanisms of Pancreatic Cancer Dissemination: The Role of the Chemokine System
Current Pharmaceutical Design Novel Derivatives of Benfluron and Dimefluron Synthesis and Anticancer activity
Letters in Drug Design & Discovery OX40 and OX40L Interaction in Cancer
Current Medicinal Chemistry Structure-activity Relationship Studies of New Marine Anticancer Agents and their Synthetic Analogues
Current Medicinal Chemistry The Role of Tumor Suppressor DLC-1: Far From Clear
Anti-Cancer Agents in Medicinal Chemistry Pulmonary Arterial Hypertension
Current Vascular Pharmacology Recent Kinase and Kinase Inhibitor X-ray Structures: Mechanisms of Inhibition and Selectivity Insights
Current Medicinal Chemistry The MDM2 Inhibitor Nutlins as an Innovative Therapeutic Tool for the Treatment of Haematological Malignancies
Current Pharmaceutical Design Can the Use of HIV-1 Derived Gene Transfer Vectors for Clinical Application be Justified?
Current Gene Therapy Novel Purine Nucleoside Analogues for Hematological Malignancies
Recent Patents on Anti-Cancer Drug Discovery Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Induction and Escalation Therapies in Multiple Sclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The cytotoxic effect of GW843682X on nasopharyngeal carcinoma
Anti-Cancer Agents in Medicinal Chemistry The Role of Cellular Plasticity in Cancer Development
Current Medicinal Chemistry The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes
Current Clinical Pharmacology Cell Hierarchy, Metabolic Flexibility and Systems Approaches to Cancer Treatment
Current Pharmaceutical Biotechnology